Management of esophageal cancer

Esophageal cancer—Outline

Esophageal carcinoma that spreads from the lining. In this dangerous disease, abnormal cells form in the esophagus, which conducts food and drink from the throat to the stomach. Anywhere in the esophagus is squamous cell carcinoma, and the lower region near the stomach can have adenocarcinoma.

Esophagus cancer

Types:

Common worldwide, squamous cell carcinoma begins in flat esophageal cells.
Adenocarcinoma starts in glandular cells in the lower esophagus and is frequent in Western countries.
Sarcoma, lymphoma, melanoma, and small cell carcinoma are infrequent.

Symptoms

Swallowing problems (the most prevalent early indication)
Burning or discomfort in the chest
Unintentional weight loss
Constant indigestion or heartburn
Hoarseness or cough
Bloody vomit or cough

Causes and Risks

Consuming heated liquids, smoking, and drinking alcohol.
Chronic acid reflux, Barrett's esophagus, and achalasia.
Obesity, low fruit/vegetable intake.
HPV and chest/abdomen radiation are further dangers.

Diagnostics:

Endoscopy with biopsy (gold standard).
CT, barium swallow, and endoscopic ultrasound.
Staging: Assesses tumour size, lymph node, and organ dissemination.

Treatment Choices

Surgical removal of the esophagus.
Endoscopic procedures: EMR, ESD, tiny tumour laser therapy.
Radiation before/after surgery or for symptoms.
Radiation and chemotherapy are common.
Immunotherapy and targeted therapy for advanced patients.

Prognosis

Stage and type affect survival:
Localized adenocarcinoma: ~51% 5-year survival.
Localized squamous carcinoma: ~35% 5-year survival.
Advanced (far spread): <10% survival.

Preventive measures:

Quit smoking and avoid alcohol.
Maintain a healthy weight and a fruit/vegetable diet.
Treat acid reflux and Barrett's esophagus medically.
Regular high-risk screening.

First signs of esophageal cancer?

Esophageal cancer begins slowly and may not show symptoms until it progresses. The most common early symptom is dysphagia, which can feel like food is stuck in the chest or throat. Heartburn, chest pain, unexplained weight loss, and chronic cough or hoarseness are some signs.

Esophageal cancer early symptoms

Swallowing problems—first solids, then liquids.
Food trapped — chest pain or obstruction.
Pain or burning in the chest—misinterpreted as heartburn.
Heartburn/GERD—reflux that doesn't improve with treatment.
Cancer metabolism or reduced food intake causes unexplained weight loss.
Hoarseness or chronic cough—vocal cord or airway inflammation.
Food vomiting, especially after meals.

Why These Signs Matter

Many benign illnesses like GERD, ulcers, and esophagitis share these symptoms.
Consult a doctor if symptoms last longer than 2–3 weeks.
Treatment outcomes improve greatly with early discovery.

Risk Factors That Increase the Chance

Drinking and smoking
Barrett's esophagus or chronic acid reflux
Low fruit/vegetable intake and obesity
Over 55
Drinking hot liquids frequently

What To Do

If you have trouble swallowing or chest pain, see a doctor.
Endoscopic biopsy is the best diagnostic method.
Early treatment options include endoscopic removal or surgery, depending on the stage.

Can treatment extend esophageal cancer survival?

Esophageal cancer survival rates vary by stage: localized disease has a 49% 5-year survival rate, regional spread 28%, and distant metastasis 5% during treatment. Across all stages, the average 5-year survival rate is 22%.

Stage-specific survival rates (U.S. SEER, 2015–2021).

Notes: Stage 5-year survival rate
Localized: ~49%. Esophageal cancer; surgery or endoscopic removal is feasible.
Regional: ~28%. Spread to neighboring lymph nodes/tissues; surgery+chemoradiation.
Distant Metastasis: ~5%; systemic therapy, palliative focus.
All stages total ~22%. Shows average survival.

Survival Factors

Adenocarcinoma has a slightly better outlook than squamous cell carcinoma.
Neoadjuvant chemoradiation followed by surgery enhances survival over chemoradiation alone.
Patient health: Nutrition, age, and concurrent diseases strongly impact outcomes.
Chemotherapy/radiation shrinks tumours, improving prognosis.
Early detection: Pre-spread diagnosis improves survival.

Important Considerations

Survival statistics are averages and do not predict individual outcomes.
Recent treatment improvements may help current patients outperform earlier statistics.
Quality of life is crucial in advanced stages.

Is esophageal cancer curable?

Esophageal cancer can be cured if identified early and vigorously treated.

Curability Factors

Cancer stage

Surgery or endoscopic removal, occasionally with radiation or chemotherapy, can cure early stages (I–II).
Stage III: Chemoradiation + surgery may cure.
Stage IV: Control and symptom alleviation; rarely curable.

Type of tumor

Localized adenocarcinoma: Better results.
Squamous cell carcinoma: Early cure, rapid spread.
Clear surgical margins improve cure rates.
Health: Younger, healthier individuals tolerate vigorous treatment better.

How to diagnose esophageal cancer?

Doctors use esophageal cancer diagnostics to directly visualize the esophagus, obtain tissue samples, and assess disease severity.

Important Diagnostic Methods

Endoscopic biopsy
Camera-equipped thin, flexible tubes are inserted into the neck.
Examine suspicious regions and take tissue samples.
The gold standard for diagnostics.
EUS endoscopic ultrasound
Uses sound waves to assess tumor invasion of the esophageal wall.
Assesses surrounding lymph nodes.

Imaging tests

CT scan: Shows chest/abdomen spread.
PET scan: Shows cancer cell metabolism.
The barium swallow X-ray involves the patient swallowing a contrast liquid to detect obstructions or narrowing.

Bronchoscopy

Sometimes used for airway cancer suspicion.

Post-Confirmation Stage

After diagnosing cancer, clinicians assess the stage by:
Tumour depth and size.
To lymph nodes.
Remote metastases (liver, lungs).

Methods of diagnosis

Upper Endoscopy (EGD): A flexible tube with a tiny camera enters the throat to observe the esophageal lining.
Endoscopy biopsy: Small tissue samples are examined under a microscope for cancer cells.
A unique scope produces close-up images of the tumour's depth in the wall using endoscopic ultrasound (EUS).

The video explains Esophageal cancer treatment options

Stage-based esophageal cancer treatment

Esophageal cancer treatment is stage-dependent. Early stages (0–I) can be treated with surgery or endoscopic removal, but advanced stages (III–IV) require chemoradiation, targeted medicines, or immunotherapy, with stage IV focused on control and quality of life.

Staged Treatments

Stage: Main Treatment Options Notes
High-grade dysplasia, stage 0. The endoscopic mucosectomy or surgery removes aberrant cells before invasion.
Stage I: Esophagectomy surgery or chemoradiation followed by surgery. Tumour type and patient health determine the curative goal.
Stage II: Chemoradiation and surgery, or surgery alone. Survivability improves with chemotherapy before surgery.
In Stage III, aggressive multimodal therapy may include surgery if the tumour is resectable.
In Stage IV, chemotherapy, immunotherapy, targeted therapy, and palliative radiation/stents are used. Prioritize symptom relief, life extension, and quality.
Treatment options for recurrent disease include immunotherapy (e.g., nivolumab), chemoimmunotherapy, and palliative. Many recommend clinical trials.

Additional Treatment Methods

Therapeutic targeting: For HER2, PD-L1-mutated cancers.
Immunotherapy: Advanced/metastatic checkpoint inhibitors.
Radiation therapy: Used before surgery to reduce tumors, after surgery to eliminate leftover cells, or alone if surgery is not possible.
Palliative care: Stents, lasers, and feeding tubes help with swallowing and nutrition.

Important Considerations

Since stage 0–I tumors are treatable, early identification is crucial.
For the greatest results, stage II–III demands strong multimodal therapy.
Stage IV is rarely treatable; survival and comfort are priorities.
Patient health and preferences substantially impact treatment.

Conclusion

Early stages are treated with curative surgery or endoscopic therapy, intermediate stages with chemoradiation and surgery, and advanced stages with systemic/palliative therapies.

Localized esophageal cancer patients can live for years, sometimes beyond five years, with treatment. Advanced cases have a shorter survival rate but can benefit from modern therapies that improve life and comfort.

Vaalga Endrum